Skip to main content
Springer Nature Link
Log in

Understanding toxic shock syndrome

  • Understanding the Disease
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. DeVries AS, Lesher L, Schlievert PM, Rogers T, Villaume LG, Danila R, Lynfield R (2011) Staphylococcal toxic shock syndrome 2000–2006: epidemiology, clinical features, and molecular characteristics. PLoS One 6:e22997

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalen C, Jasir A (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46:2359–2367

    Article  PubMed Central  PubMed  Google Scholar 

  3. Kain KC, Schulzer M, Chow AW (1993) Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminant analyses. Clin Infect Dis 16:100–106

    Article  CAS  PubMed  Google Scholar 

  4. Descloux E, Perpoint T, Ferry T, Lina G, Bes M, Vandenesch F, Mohammedi I, Etienne J (2008) One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis 27:37–43

    Article  CAS  PubMed  Google Scholar 

  5. Hajjeh RA, Reingold A, Weil A, Shutt K, Schuchat A, Perkins BA (1999) Toxic shock syndrome in the United States: surveillance update, 1979 1996. Emerg Infect Dis 5:807–810

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Centers for Disease Control and Prevention (2011) Toxic shock syndrome (other than streptococcal) (TSS); 2011 case definition. http://wwwn.cdc.gov/nndss/conditions/toxic-shock-syndrome-other-than-streptococcal/case-definition/2011/. Accessed 3 Apr 2015

  7. Parsonnet J, Hansmann MA, Delaney ML, Modern PA, Dubois AM, Wieland-Alter W, Wissemann KW, Wild JE, Jones MB, Seymour JL, Onderdonk AB (2005) Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol 43:4628–4634

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE (1996) Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 335:547–554

    Article  CAS  PubMed  Google Scholar 

  9. Centers for Disease Control and Prevention (2010) Streptococcal toxic-shock syndrome (STSS) (Streptococcus pyogenes); 2010 case definition. http://wwwn.cdc.gov/nndss/conditions/streptococcal-toxic-shock-syndrome/case-definition/2010/. Accessed 3 Apr 2015

  10. Holm SE, Norrby A, Bergholm AM, Norgren M (1992) Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988–1989. J Infect Dis 166:31–37

    Article  CAS  PubMed  Google Scholar 

  11. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, Tang AW, Phung TO, Spellberg B (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352:1445–1453

    Article  CAS  PubMed  Google Scholar 

  12. Schlievert PM (1986) Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1:1149–1150

    Article  CAS  PubMed  Google Scholar 

  13. Lee VT, Chang AH, Chow AW (1992) Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates. J Infect Dis 166:911–915

    Article  CAS  PubMed  Google Scholar 

  14. Stevens DL, Wallace RJ, Hamilton SM, Bryant AE (2006) Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics. Clin Infect Dis 42:729–730

    Article  PubMed  Google Scholar 

  15. Carapetis JR, Jacoby P, Carville K, Ang SJ, Curtis N, Andrews R (2014) Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis 59:358–365

    Article  CAS  PubMed  Google Scholar 

  16. Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE (2007) Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 195:202–211

    Article  CAS  PubMed  Google Scholar 

  17. Coyle EA, Cha R, Rybak MJ (2003) Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release. Antimicrob Agents Chemother 47:1752–1755

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37:333–340

    Article  CAS  PubMed  Google Scholar 

  19. Linner A, Darenberg J, Sjolin J, Henriques-Normark B, Norrby-Teglund A (2014) Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 59:851–857

    Article  CAS  PubMed  Google Scholar 

  20. Matsushima A, Kuroki Y, Nakajima S, Sakai T, Kojima H, Ueyama M (2014) Low level of TSST-1 antibody in burn patients with toxic shock syndrome caused by methicillin-resistant Staphylococcus aureus. J Burn Care Res. doi:10.1097/BCR.0000000000000128

    Google Scholar 

Download references

Conflicts of interest

Dr. Burnham has no conflicts of interest to report. Dr. Kollef’s effort was supported by the Barnes-Jewish Hospital Foundation.

Author information

Authors and Affiliations

  1. Division of Medical Education, Washington University School of Medicine, St. Louis, MO, USA

    Jason P. Burnham

  2. Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA

    Marin H. Kollef

Authors
  1. Jason P. Burnham
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Marin H. Kollef
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Marin H. Kollef.

Additional information

This work was performed at Barnes-Jewish Hospital, St. Louis, MO.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burnham, J.P., Kollef, M.H. Understanding toxic shock syndrome. Intensive Care Med 41, 1707–1710 (2015). https://doi.org/10.1007/s00134-015-3861-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-015-3861-7

Keywords

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy